Aquatic Capital Management’s TG Therapeutics TGTX Stock Holding History

Aquatic Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.47M	Buy	99,530 +20,440	+26%	+$837K	0.19%	124
2026 Q1	$2.63M	Buy	79,090 +35,850	+83%	+$1.07M	0.08%	318
2025 Q4	$1.29M	Sell	43,240 -32,248	-43%	-$1.05M	0.04%	484
2025 Q3	$2.73M	Buy	+75,488	New	+$2.49M	0.05%	414
2024 Q4	–	Sell	-51,900	Closed	-$1.21M	–	1608
2024 Q3	$1.21M	Buy	+51,900	New	+$1.13M	0.03%	464
2024 Q2	–	Sell	-191,900	Closed	-$2.92M	–	1596
2024 Q1	$2.92M	Buy	191,900 +180,600	+1,598%	+$2.88M	0.1%	198
2023 Q4	$193K	Sell	11,300 -3,500	-24%	-$40.7K	﹤0.01%	858
2023 Q3	$124K	Buy	+14,800	New	+$206K	0.01%	779
2023 Q2	–	Sell	-20,800	Closed	-$313K	–	1741
2023 Q1	$313K	Buy	+20,800	New	+$316K	0.02%	503
2022 Q4	–	Sell	-3,000	Closed	-$18K	–	1817
2022 Q3	$18K	Sell	3,000 -400	-12%	-$2.62K	﹤0.01%	1005
2022 Q2	$14K	Buy	3,400 +1,500	+79%	+$9.37K	﹤0.01%	911
2022 Q1	$18K	Buy	+1,900	New	+$22K	0.03%	523

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Aquatic Capital Management's TGTX Position: Q2 2026 in Review

Aquatic Capital Management increased its TG Therapeutics (TGTX) stake by 26% in Q2 2026, buying an estimated $837K and bringing the position to 99,530 shares worth $5.47M. The position accounts for 0.19% of the portfolio, ranked #124.

Aquatic Capital Management first reported a position in TGTX in Q1 2022 and has held it in 12 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Aquatic Capital Management held 99,530 shares of TG Therapeutics worth $5.47M as of Q2 2026.
Aquatic Capital Management bought 20,440 TG Therapeutics shares in Q2 2026, an estimated $837K.
TG Therapeutics made up 0.19% of Aquatic Capital Management's portfolio in Q2 2026, its #124 holding.
Aquatic Capital Management first reported a position in TG Therapeutics in Q1 2022 and has held it in 12 quarters since.
430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.